Biopalette is a operator of a platform intended to offer gene-editing techniques.
Biopalette is a operator of a platform intended to offer gene-editing techniques. Bio Palette plans to develop our business in three fields, classified based on the type of cells targeted for genome editing.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 24, 2020 | Series A | ¥1B | 1 | — | — | Detail |
| Jun 20, 2018 | Seed | $5.20M | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series A |